MedTrace Logo

Pathology Analysis of OPMD Patient Myotomies

NCT03874910 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-03-21

No results posted yet for this study

Summary

The study aims to characterize the effect of OPMD mutation on muscle function. Muscle samples will be received from oculopharyngeal muscular dystrophy (OPMD) patients who undergo cricopharyngeal muscle-cutting surgery, as part of their routine healthcare and treatment.

Conditions

  • Oculopharyngeal Muscular Dystrophy

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Itzhak Braverman, Doctor (MD) · Hillel Yaffe Medical Center, Israel

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-19
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874910 on ClinicalTrials.gov